Natrilix SR

Natrilix SR





Concise Prescribing Info
Dosage/Direction for Use
1 tab daily preferably in the morning.
Should be taken with food: Swallow whole, do not chew/crush.
Hypersensitivity to indapamide or other sulfonamides. Hypokalaemia. Severe renal failure; hepatic encephalopathy or severe impairment of liver function.
Special Precautions
Discontinue in cases of hepatic encephalopathy; photosensitivity. May increase tendency to gout attacks in hyperuricaemic patients. Monitor plasma Na, K, Ca & blood glucose. May give a positive reaction in doping tests. Not to be taken by patients w/ rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. May impair ability to drive vehicles or operate machinery. Preexisting renal insufficiency. Avoid use during pregnancy. Not to be used during lactation. Childn & adolescents.
Adverse Reactions
Hypersensitivity reactions, maculopapular rashes.
Drug Interactions
Increased risk of ventricular arrhythmias w/ torsades de pointes-inducing drugs eg, class Ia (quinidine, hydroquinidine, disopyramide) & III (amiodarone, sotalol, dofetilide, ibutilide) antiarrhythmics, antipsychotics eg, phenothiazines (chlorpromazine, cyamemazine, levomepromazine, thioridazine, trifluoperazine), benzamides (amisulpride, sulpiride, sultopride, tiapride), butyrophenones (droperidol, haloperidol); bepridil, cisapride, diphemanil, erythromycin IV, halofantrine, mizolastine, pentamidine, sparfloxacin, moxifloxacin, vincamine IV. Possible reduction in antihypertensive effect w/ NSAIDs (systemic) eg, COX-2 selective inhibitors, high-dose salicylic acid (3 g daily). Risk of sudden hypotension &/or acute renal failure w/ ACE inhibitors. Increased risk of hypokalaemia w/ amphotericin B (IV), gluco- & mineralocorticoids (systemic), tetracosactide, stimulant laxatives. Increased antihypertensive effect w/ baclofen. Hypokalaemia predisposing to the toxic effects of digitalis. May increase incidence of hypersensitivity reactions to allopurinol. Hypokalaemia or hyperkalaemia (particularly in patients w/ renal failure & diabetes) may occur w/ K-sparing diuretics (amiloride, spironolactone, triamterene). Increased risk of metformin-induced lactic acidosis. Increased risk of acute renal failure w/ iodinated contrast media (large doses). Increased antihypertensive effect & risk of orthostatic hypotension w/ imipramine-like antidepressants, neuroleptics. Risk of hypercalcaemia w/ Ca salts. Risk of increased plasma creatinine w/ ciclosporin, tacrolimus. Decreased antihypertensive effect w/ corticosteroids, tetracosactide (systemic). Not recommended: Increased plasma lithium.
MIMS Class
ATC Classification
C03BA11 - indapamide ; Belongs to the class of low-ceiling sulfonamide diuretics.
Natrilix SR coated tab 1.5 mg
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in